⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VIR News
Vir Biotechnology, Inc. Common Stock
Vir Biotechnology to Host Conference Call for First Quarter 2026 Financial Results
businesswire.com
VIR
Vir Biotechnology Announces First Patient Dosed in Phase 1 Dose-expansion Cohorts Evaluating PSMA-targeted, PRO-XTEN ® Dual-masked T-cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer
businesswire.com
VIR
Form 8-K
sec.gov
VIR
Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types
prnewswire.com
IOVA
VIR
CCCC
ONCY
IMCR
Form 8-K
sec.gov
VIR
Form 8-K
sec.gov
VIR
Form 8-K
sec.gov
VIR
Vir Biotechnology to Participate in Upcoming Investor Conferences
businesswire.com
VIR
genOway: Revolutionizing the Prediction of Antibody Therapies in Humans with Unique Mouse Model USA - English USA - español USA - Français USA - English Japan - Japanese USA - Deutsch
prnewswire.com
VIR
genOway : révolutionner la prédiction des thérapies à base d'anticorps chez l'humain grâce à un modèle murin unique USA - Français USA - español USA - English Japan - Japanese USA - Deutsch
prnewswire.com
VIR
GILD